GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio
Increased Risk for CVD Seen for Women With Premenstrual Disorders
Risk particularly pronounced for PMDs diagnosed before 25 years of age and those with comorbid perinatal depression
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
Increased cardiovascular risk over five years also seen in association with delayed diagnosis
Nocturnal Hypertension Control Improved With Bedtime Antihypertensive Dosing
Better control of nocturnal blood pressure and improved circadian rhythm seen with bedtime versus daytime dosing
Most U.S. Adults Lack Awareness of Processed Foods
Authors propose replacing the term 'processed foods' with more specific terms describing foods’ known health effects
Kerendia Approved for Heart Failure With Left Ventricular Ejection Fraction ≥40 Percent
Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart failure
RFK Jr. Cancels Key U.S. Health Panel Meeting Without Warning, Raising Concerns
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
Consistently and increasingly active individuals have lower risks for all-cause, CVD mortality
Hypercholesterolemia Treatment Falls Short of Guidelines
In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines
